Diagnostic Strategy Using Color Doppler Ultrasound of Temporal Arteries in Patients With High Clinical Suspicion of Giant Cell Arteritis : A Prospective Cohort Study.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
07 May 2024
Historique:
medline: 6 5 2024
pubmed: 6 5 2024
entrez: 6 5 2024
Statut: aheadofprint

Résumé

Giant cell arteritis (GCA) is the most prevalent systemic vasculitis in people older than 50 years. Any delay in diagnosis impairs patients' quality of life and can lead to permanent damage, particularly vision loss. To evaluate a diagnostic strategy for GCA using color Doppler ultrasound of the temporal artery as a first-line diagnostic test, temporal artery biopsy (TAB) as a secondary test, and physician expertise as the reference method. Prospective multicenter study with a 2-year follow-up. (ClinicalTrials.gov: NCT02703922). Patients were referred by their general practitioner or ophthalmologist to a physician with extensive experience in GCA diagnosis and management in one of the participating centers: 4 general and 2 university hospitals. 165 patients with high clinical suspicion of GCA, aged 79 years (IQR, 73 to 85 years). The diagnostic procedure was ultrasound, performed less than 7 days after initiation of corticosteroid therapy. Only ultrasound-negative patients underwent TAB. Bilateral temporal halo signs seen on ultrasound were considered positive. Ultrasound and TAB results were compared with physician-diagnosed GCA based on clinical findings and other imaging. Diagnosis of GCA was confirmed in 44%, 17%, and 21% of patients by ultrasound, TAB, and clinical expertise and/or other imaging tests, respectively. Their diagnosis remained unchanged at 1 month, and 2 years for those with available follow-up data. An alternative diagnosis was made in 18% of patients. The proportion of ultrasound-positive patients among patients with a clinical GCA diagnosis was 54% (95% CI, 45% to 62%). Small sample size, no blinding of ultrasound and TAB results, lack of an objective gold-standard comparator, and single diagnostic strategy. By using ultrasound of the temporal arteries as a first-line diagnostic tool in patients with high clinical suspicion of GCA, further diagnostic tests for patients with positive ultrasound were avoided. Tender "Recherche CH-CHU Poitou-Charentes 2014."

Sections du résumé

BACKGROUND UNASSIGNED
Giant cell arteritis (GCA) is the most prevalent systemic vasculitis in people older than 50 years. Any delay in diagnosis impairs patients' quality of life and can lead to permanent damage, particularly vision loss.
OBJECTIVE UNASSIGNED
To evaluate a diagnostic strategy for GCA using color Doppler ultrasound of the temporal artery as a first-line diagnostic test, temporal artery biopsy (TAB) as a secondary test, and physician expertise as the reference method.
DESIGN UNASSIGNED
Prospective multicenter study with a 2-year follow-up. (ClinicalTrials.gov: NCT02703922).
SETTING UNASSIGNED
Patients were referred by their general practitioner or ophthalmologist to a physician with extensive experience in GCA diagnosis and management in one of the participating centers: 4 general and 2 university hospitals.
PATIENTS UNASSIGNED
165 patients with high clinical suspicion of GCA, aged 79 years (IQR, 73 to 85 years).
INTERVENTION UNASSIGNED
The diagnostic procedure was ultrasound, performed less than 7 days after initiation of corticosteroid therapy. Only ultrasound-negative patients underwent TAB.
MEASUREMENTS UNASSIGNED
Bilateral temporal halo signs seen on ultrasound were considered positive. Ultrasound and TAB results were compared with physician-diagnosed GCA based on clinical findings and other imaging.
RESULTS UNASSIGNED
Diagnosis of GCA was confirmed in 44%, 17%, and 21% of patients by ultrasound, TAB, and clinical expertise and/or other imaging tests, respectively. Their diagnosis remained unchanged at 1 month, and 2 years for those with available follow-up data. An alternative diagnosis was made in 18% of patients. The proportion of ultrasound-positive patients among patients with a clinical GCA diagnosis was 54% (95% CI, 45% to 62%).
LIMITATION UNASSIGNED
Small sample size, no blinding of ultrasound and TAB results, lack of an objective gold-standard comparator, and single diagnostic strategy.
CONCLUSION UNASSIGNED
By using ultrasound of the temporal arteries as a first-line diagnostic tool in patients with high clinical suspicion of GCA, further diagnostic tests for patients with positive ultrasound were avoided.
PRIMARY FUNDING SOURCE UNASSIGNED
Tender "Recherche CH-CHU Poitou-Charentes 2014."

Identifiants

pubmed: 38710093
doi: 10.7326/M23-3417
doi:

Banques de données

ClinicalTrials.gov
['NCT02703922']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Guillaume Denis (G)

Department of Internal Medicine and Hematology, Centre Hospitalier Rochefort, Rochefort, France (G.Denis, C.D.).

Olivier Espitia (O)

Department of Internal and Vascular Medicine, l'Institut du Thorax, INSERM UMR 1087/CNRS UMR 6291, Nantes; and Team III Vascular & Pulmonary Diseases, Nantes Université, CHU Nantes, Nantes, France (O.E., C.A.-B., A.Raimbeau, G.G.).

Caroline Allix-Béguec (C)

Department of Internal and Vascular Medicine, l'Institut du Thorax, INSERM UMR 1087/CNRS UMR 6291, Nantes; and Team III Vascular & Pulmonary Diseases, Nantes Université, CHU Nantes, Nantes, France (O.E., C.A.-B., A.Raimbeau, G.G.).

Céline Dieval (C)

Department of Internal Medicine and Hematology, Centre Hospitalier Rochefort, Rochefort, France (G.Denis, C.D.).

Fanny Lorcerie (F)

Department of Vascular Medicine, Centre Hospitalier Rochefort, Rochefort, France (F.L.).

Bruno Gombert (B)

Department of Rheumatology, Centre Hospitalier La Rochelle, La Rochelle, France (B.G.).

Xavier Pouget-Abadie (X)

Department of Internal Medicine and Infectious Diseases, Centre Hospitalier La Rochelle, La Rochelle, France (X.P.-A.).

Claire Toquet (C)

Department of Pathology, l'Institut du Thorax, INSERM UMR 1087/CNRS UMR 6291, Nantes Université, CHU Nantes, Nantes, France (C.T.).

Christian Agard (C)

Department of Clinical Research, Centre Hospitalier La Rochelle, La Rochelle, France (C.A.).

Alizée Raimbeau (A)

Department of Internal and Vascular Medicine, l'Institut du Thorax, INSERM UMR 1087/CNRS UMR 6291, Nantes; and Team III Vascular & Pulmonary Diseases, Nantes Université, CHU Nantes, Nantes, France (O.E., C.A.-B., A.Raimbeau, G.G.).

Giovanni Gautier (G)

Department of Internal and Vascular Medicine, l'Institut du Thorax, INSERM UMR 1087/CNRS UMR 6291, Nantes; and Team III Vascular & Pulmonary Diseases, Nantes Université, CHU Nantes, Nantes, France (O.E., C.A.-B., A.Raimbeau, G.G.).

Jean-Michel Goujon (JM)

Department of Pathology, CHU Poitiers, Poitiers, France (J.-M.G.).

Géraldine Durand (G)

Department of Rheumatology, CHU Poitiers, Poitiers, France (G.Durand).

Cécile Thollot-Karolewicz (C)

Department of Vascular Medicine, CHU Poitiers, Poitiers, France (C.T.-K.).

Christian Lormeau (C)

Department of Rheumatology, Centre Hospitalier Niort, Niort, France (C.Lormeau).

Aurélie Grados (A)

Department of Internal Medicine, Centre Hospitalier Niort, Niort, France (A.G.).

Anne Grenot-Mercier (A)

Department of Vascular Medicine, Centre Hospitalier Niort, Niort, France (A.G.-M.).

Rony El-Khoury (R)

Department of Pathology, Centre Hospitalier Niort, Niort, France (R.E.).

Agnès Riche (A)

Department of Internal Medicine, Centre Hospitalier Angoulême, Angoulême, France (A.Riche).

Florence Hospital (F)

Department of Vascular Medicine, Centre Hospitalier Angoulême, Angoulême, France (F.H.).

Sebastien Visee (S)

Department of Pathology, Centre Hospitalier Angoulême, Angoulême, France (S.V.).

Marie-Luce Auriault (ML)

Department of Pathology, Centre Hospitalier La Rochelle, La Rochelle, France (M.-L.A.).

Cédric Landron (C)

Department of Internal Medicine, CHU Poitiers, Poitiers, France (C.Landron).

Mickaël Martin (M)

Department of Internal Medicine, INSERM U1313, Poitiers University, Poitiers University Hospital, Poitiers, France (M.M.).

Christophe Roncato (C)

Department of Vascular Medicine, Centre Hospitalier La Rochelle, La Rochelle, France (C.R.).

Classifications MeSH